The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management-A multicenter retrospective study by R. Mahieu et al.
The prognosis of streptococcal prosthetic bone and joint
infections depends on surgical management-A multicenter
retrospective study
Submitted by Stéphanie Pinot on Wed, 09/25/2019 - 16:14
Titre The prognosis of streptococcal prosthetic bone and joint infections depends onsurgical management-A multicenter retrospective study
Type de
publication Article de revue
Auteur
Mahieu, Rafaël [1], Dubée, Vincent [2], Seegers, Valérie [3], Lemarié, Carole [4],
Ansart, Séverine [5], Bernard, Louis [6], Le Moal, Gwenaël [7], Asseray, Nathalie
[8], Arvieux, Cédric [9], Ramanantsoa, Céline [10], Cormier, Hélène [11], Legrand,
Erick [12], Abgueguen, Pierre [13]
Organisme CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest)Study Group [14]
Editeur Elsevier











BACKGROUND: The optimal treatment of streptococcal prosthetic joint infections
(PJIs) is unclear.
METHODS: A cohort of streptococcal PJIs was reviewed retrospectively in seven
reference centers for the management of complex bone and joint infections,
covering the period January 1, 2010 to December 31, 2012.
RESULTS: Seventy patients with monomicrobial infections were included: 47 had
infections of total hip arthroplasty and 23 had infections of total knee arthroplasty.
The median age was 77 years (interquartile range (IQR) 69-83 years), the median
Charlson comorbidity score was 4 (IQR 3-6), and 15.6% (n=11) had diabetes. The
most commonly identified streptococcal species were Streptococcus agalactiae and
Streptococcus dysgalactiae (38.6% (n=27) and 17.1% (n=12), respectively).
Debridement, antibiotics and implant retention (DAIR) was performed after a
median time of 7 days (IQR 3-8 days), with polyethylene exchange (PE) in 21% of
cases. After a minimum follow-up of 2 years, 27% of patients had relapsed,
corresponding to 51.4% of DAIR treatment cases and 0% of one-stage (n=15) or
two-stage (n=17) exchange strategy cases. Rifampicin or levofloxacin in
combination therapy was not associated with a better outcome (adjusted p= 0.99).
S. agalactiae species and DAIR treatment were associated with a higher risk of
failure. On multivariate analysis, only DAIR treatment and S. agalactiae were
independent factors of relapse. Compared to DAIR without PE, DAIR with PE was
only associated with a trend towards a benefit (odds ratio 0.33, 95% confidence
interval 0.06-1.96; adjusted p= 0.44).
CONCLUSIONS: Streptococcal PJIs managed with DAIR have a poor prognosis and
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